Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic Impairment

Clinical trial NCT02170220 · COMPLETED

Trial details

NCT number: NCT02170220
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Hepatic Impairment

Start date: 2014-07-01
Primary completion: 2014-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.